守護者聯盟 UG 深 滬
等待開盤 08-10 09:30:00 美东时间
7.29
+0.055
+0.76%
華盛通- 最 高7.913
- 今 開7.13
- 成交量 2.50万股
- 最 低 7.11
- 昨 收 7.235
- 總市值 3349.26万
- 52周最高 8.225
- 市盈率 靜 15.91
- 換手率 0.54%
- 52周最低 5.0253
- 委 比 98.72%
- 總股本 459.43万
- 歷史最高 25.99
- 量 比 3.12
- 振 幅 11.10%
- 歷史最低 2.38
- 每 手 1
- 風險率 0.69%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多United-Guardian Q2 EPS $0.16 Up From $0.14 YoY, Sales $3.108M Up From $2.838M YoY
United-Guardian (NASDAQ:UG) reported quarterly earnings of $0.16 per share. This is a 14.29 percent increase over earnings of $0.14 per share from the same period last year. The company reported $3.108 million in sales this quarter. This is a 9.51 percent increase over sales of $2.838 million the sa...
08-07 22:46
United-Guardian Reports Second Quarter Results
United-Guardian, Inc. reported a 10% increase in Q2 2026 net sales to $3.108 million and a 16% rise in net income to $728,579 compared to Q2 2025. For the first half of 2026, net sales rose 12% to $5.98 million, and net income increased 30% to $1.547 million. Cosmetic ingredient sales surged 44% in Q2 and 34% in H1, driven by increased purchases from ASI. Pharmaceutical sales grew 1% in Q2 and 11% in H1, with Renacidin® as the key driver. The com...
08-07 14:30
United-Guardian Declares Cash Dividend
United-Guardian, Inc. announced a $0.30 per share cash dividend, marking its 31st consecutive year of dividend payments. This represents a 20% increase from the February dividend, reflecting the company's financial performance and confidence in future growth. United-Guardian manufactures specialty cosmetic, personal care, sexual wellness ingredients, and healthcare products.
07-16 13:00
United-Guardian Q1 EPS $0.18 Up From $0.12 YoY, Sales $2.872M Up From $2.481M YoY
United-Guardian (NASDAQ:UG) reported quarterly earnings of $0.18 per share. This is a 50 percent increase over earnings of $0.12 per share from the same period last year. The company reported $2.872 million in sales
05-08 21:07
United-Guardian Reports First Quarter Results
United-Guardian, Inc. reported a 16% increase in Q1 2026 sales to $2.87 million from $2.48 million in Q1 2025, with net income rising 46% to $818,902 ($0.18 per share) from $560,895 ($0.12 per share). Growth was driven by a 24% surge in pharmaceutical sales, particularly Renacidin®, and a 21% boost in cosmetic ingredients sales, mainly due to a 45% increase in purchases by ASI. The company also benefited from $303,133 in settlement income related...
05-08 13:00
Scott Bessent Says Fed Is 'Doing The Right Thing' By Sitting And Watching' On Interest Rates Amid Iran War Uncertainty
U.S. Treasury Secretary Scott Bessent urged the Federal Reserve to "wait and see" on rate cuts amid Iran-related uncertainty. He maintained that recent price spikes—largely driven by surging gasoline costs—are unlikely to shift long-term inflation expectations, as underlying price pressures remain contained.
04-14 15:10
Ditching SPY, QQQ? These Unconventional ETFs Lead 2026 Gains
As SPY and QQQ struggle this year, investors are rotating into niche ETFs tied to energy, commodities, and global shipping trends.
04-07 02:20
American Drivers Hit With $8.4 Billion In Extra Costs Since Iran War Began: 'Additional $240 Million Per Day'
U.S. drivers face $8.4 billion in extra fuel costs since the Iran War began. Gas hits $4.10/gal as costs rise by $240 million daily.
04-05 16:27
United-Guardian Q4 EPS $0.14 Up From $0.11 YoY, Sales $2.962M Up From $2.477M YoY
United-Guardian (NASDAQ:UG) reported quarterly earnings of $0.14 per share. This is a 27.27 percent increase over earnings of $0.11 per share from the same period last year. The company reported $2.962 million in sales
03-27 21:05
United-Guardian Reports 2025 Financial Results
United-Guardian, Inc. reported a 13% decline in net sales and a 35% drop in net income for FY 2025 compared to FY 2024. The decrease was driven by reduced sales of cosmetic ingredients, attributed to excess inventory with a major distributor and decreased global demand, particularly in China due to local competition and tariffs. However, sales of pharmaceuticals and medical lubricants increased by 15% and 4%, respectively, supported by higher dem...
03-27 13:00
